Rokus van Iperen, Chairman of the Supervisory Board (SB) of the Máxima Center: 'We are very pleased that Dagmar Enklaar will strengthen our Board. The Princess Máxima Center is a leading research hospital, working at the forefront of research into new diagnostic and treatment methods and the development of new drugs in pediatric oncology. Dagmar brings extensive knowledge and experience in the healthcare sector, where data analytics and AI are playing an increasingly important role. She succeeds Barbara Fransen, to whom we are very grateful for her great contribution to the creation of our beautiful center.’
New Commissioner
For the past 25 years, Dagmar Enklaar has worked for various consulting organizations in the field of mergers and acquisitions, mainly in the healthcare sector. For eight years she was also a member of the Supervisory Board of the Noordwest Hospital Group, a group of top clinical hospitals in North Holland. Dagmar is excited about this great addition to her daily work at Deloitte: ‘The Princess Máxima Center plays a very important role in curing childhood cancer. Everything is done to ensure that children have the best possible experience during their treatment at the hospital. I am very much looking forward to contributing to this by dedicating myself to this beautiful hospital and working together with the other members of the Supervisory Board and the Board of Directors.’
Composition of the Supervisory Board
The Supervisory Board of Prinses Máxima Center now consists of chairman Rokus van Iperen, vice chair Houke Klomp, Kees Buijsrogge, Johan van der Werf, Tjahny Bercx and Dagmar Enklaar.